IT7826609A0 - Composizione farmaceutica solida comprendente lo scheletro di pareti cellulari. - Google Patents

Composizione farmaceutica solida comprendente lo scheletro di pareti cellulari.

Info

Publication number
IT7826609A0
IT7826609A0 IT7826609A IT2660978A IT7826609A0 IT 7826609 A0 IT7826609 A0 IT 7826609A0 IT 7826609 A IT7826609 A IT 7826609A IT 2660978 A IT2660978 A IT 2660978A IT 7826609 A0 IT7826609 A0 IT 7826609A0
Authority
IT
Italy
Prior art keywords
skeleton
pharmaceutical composition
composition including
cell walls
solid pharmaceutical
Prior art date
Application number
IT7826609A
Other languages
English (en)
Other versions
IT1098381B (it
Original Assignee
Yamamura Yuichi
Aoki Osamu
Takarazuka Giappone
Azuma Ichiro
Suita Giappone
Ennyu Katsusuke
Takatsuki Giappone
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamamura Yuichi, Aoki Osamu, Takarazuka Giappone, Azuma Ichiro, Suita Giappone, Ennyu Katsusuke, Takatsuki Giappone filed Critical Yamamura Yuichi
Publication of IT7826609A0 publication Critical patent/IT7826609A0/it
Application granted granted Critical
Publication of IT1098381B publication Critical patent/IT1098381B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT26609/78A 1977-08-09 1978-08-08 Composizione farmaceutica solida comprendente lo scheletro di pareti cellulari IT1098381B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9587177A JPS5428813A (en) 1977-08-09 1977-08-09 Solid preparation containing cell membrane extract substance used as suspension when using same

Publications (2)

Publication Number Publication Date
IT7826609A0 true IT7826609A0 (it) 1978-08-08
IT1098381B IT1098381B (it) 1985-09-07

Family

ID=14149407

Family Applications (1)

Application Number Title Priority Date Filing Date
IT26609/78A IT1098381B (it) 1977-08-09 1978-08-08 Composizione farmaceutica solida comprendente lo scheletro di pareti cellulari

Country Status (15)

Country Link
US (1) US4543253A (it)
JP (1) JPS5428813A (it)
AU (1) AU526788B2 (it)
BE (1) BE869610A (it)
CA (1) CA1118348A (it)
CH (1) CH643459A5 (it)
DE (1) DE2834893A1 (it)
DK (1) DK153443C (it)
FI (1) FI65370C (it)
FR (1) FR2399844A1 (it)
GB (1) GB2002229B (it)
HU (1) HU179726B (it)
IT (1) IT1098381B (it)
NL (1) NL7808337A (it)
SE (1) SE447629B (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1206416A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
CA1206415A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
US4806350A (en) * 1986-04-18 1989-02-21 Norden Laboratories, Inc. Vaccine formulation
DD273198A5 (de) * 1986-06-09 1989-11-08 �������@�������k���Kk�� Verfahren zur herstellung eines modifikationsmittels
DE3727987A1 (de) * 1987-08-21 1989-03-02 Sleytr Uwe B Pharmazeutische struktur
US6090385A (en) * 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
KR100628007B1 (ko) * 1998-07-16 2006-09-26 이치로 아즈마 세균의 균체성분을 유효성분으로 하는 암면역요법용 제제
JP4726485B2 (ja) * 2002-08-02 2011-07-20 大日本住友製薬株式会社 細菌細胞壁骨格成分製剤
CA2564180A1 (en) * 2004-04-22 2005-11-03 Dainippon Sumitomo Pharma Co., Ltd. Pharmaceutical preparation containing bacterial cell wall skeleton component
CN115300490B (zh) * 2021-05-07 2024-04-16 安徽远望乐桓药业有限公司 包含角鲨烯和甘露醇的药物组合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3185623A (en) * 1960-05-31 1965-05-25 Smith Fred Preservation of animal semen
US3177117A (en) * 1961-12-26 1965-04-06 Joseph F Saunders Process for freezing blood
FR2268531B1 (it) * 1974-04-25 1978-07-21 Anvar
DE2527636A1 (de) * 1974-06-20 1976-01-08 Anvar Verfahren zur herstellung von mycobakteriellen fraktionen
FR2345159A2 (fr) * 1976-03-26 1977-10-21 Anvar Agents solubles dans l'eau ayant des proprietes mitogenes et/ou immuno-stimulantes, obtenus a partir de cellules de nocardia, et leurs procedes de preparation
FR2345158A1 (fr) * 1976-03-26 1977-10-21 Anvar Agents mitogenes, provenant notamment de peptidoglycanes bacteriens

Also Published As

Publication number Publication date
US4543253A (en) 1985-09-24
BE869610A (fr) 1979-02-08
AU3879178A (en) 1980-02-14
HU179726B (en) 1982-11-29
FR2399844A1 (fr) 1979-03-09
FR2399844B1 (it) 1982-08-20
DK352578A (da) 1979-02-10
DK153443C (da) 1988-12-05
SE7808414L (sv) 1979-02-10
JPS5428813A (en) 1979-03-03
AU526788B2 (en) 1983-02-03
DK153443B (da) 1988-07-18
FI782442A7 (fi) 1979-02-10
DE2834893C2 (it) 1987-08-27
CH643459A5 (de) 1984-06-15
FI65370B (fi) 1984-01-31
GB2002229B (en) 1982-05-26
SE447629B (sv) 1986-12-01
DE2834893A1 (de) 1979-02-22
NL7808337A (nl) 1979-02-13
IT1098381B (it) 1985-09-07
JPS631291B2 (it) 1988-01-12
FI65370C (fi) 1984-05-10
CA1118348A (en) 1982-02-16
GB2002229A (en) 1979-02-21

Similar Documents

Publication Publication Date Title
IT7826631A0 (it) Preparazione di oligoimmidi.
SE7810591L (sv) Farmaceutiska kompositioner
SE7810191L (sv) Kemisk komposition
BE872319A (fr) Composition pharmaceutique
IT7826192A0 (it) Preparazione di isocianurati.
MX148578A (es) Estructura mejorada combinada de electrolito-electrodo
IT7822713A0 (it) Composizioni cementizie.
IT7826609A0 (it) Composizione farmaceutica solida comprendente lo scheletro di pareti cellulari.
NL7806528A (nl) Bereiding van salpeterzuur.
IT7821686A0 (it) Composizione farmaceutica.
IT7885554A0 (it) Perfezionamenti al procedimento di formatura di corpi cavi.
PL204502A1 (pl) Kompozycje chemiczne
IT7829060A0 (it) Procedimento per la prepoarazione di alogeno-vinil-delta-butirrolattoni.
NO783223L (no) Konstruksjon for utnyttelse av havbunnen
SE7806441L (sv) Lekemedelskomposition
NL7804503A (nl) Bereiding van 1-n-omega -amino-alpha-hydroxyalkanoyl kanamycinen.
IT7826596A0 (it) Procedimento per la preparazione di funanoni.
NL7806111A (nl) Bereiding van difenylethers.
IT7828659A0 (it) Procedimento per la fabbricazione di nitroguanidina.
IT1096303B (it) Struttura di bloccaggio
ES255416Y (es) Armazon o esqueleto de construccion, de volumen solido
FI781507A7 (fi) Farmaceutiska kompositioner
NL167100B (nl) Menger.
IT7824253A0 (it) Procedimento per la preparazione di stirene.
SE7813062L (sv) Farmaceutisk komposition

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970829